A Comparison between Single and Double-Dose Intravenous Ketamine Administration in Bipolar Mood Disorder: A Double-Blind Controlled Clinical Trial

Objectives: As glutamatergic system dysfunction is involved in bipolar depression pathophysiology, the glutamate receptor modulators such as Ketamine have been applied as complementary medication for mood stabilizers. While the treatment is currently just the intravenous injection of a single dose,...

Full description

Bibliographic Details
Main Authors: Ali Talaei, Farhad Farid Hoseini, Meisam Mahdavi, Maryam Salehi, Asieh Karimani, Fahimeh Afzaljavan
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2023-09-01
Series:Iranian Journal of Psychiatry
Subjects:
Online Access:https://ijps.tums.ac.ir/index.php/ijps/article/view/2880